Sale!

SMN1 Gene Spinal Muscular Atrophy Type 4 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The SMN1 Gene Spinal Muscular Atrophy Type 4 NGS Genetic DNA Test is a cutting-edge genetic screening that identifies mutations in the SMN1 gene responsible for Spinal Muscular Atrophy Type 4. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect genetic variations that cause this adult-onset neurological disorder. The test is crucial for individuals experiencing muscle weakness, family history of SMA, or planning pregnancy. Results provide valuable insights for early intervention, treatment planning, and informed family decisions. The test costs $500 USD and offers a comprehensive analysis of the SMN1 gene with high accuracy and reliability.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

SMN1 Gene Spinal Muscular Atrophy Type 4 NGS Genetic DNA Test

Comprehensive Genetic Testing for Spinal Muscular Atrophy Type 4

Spinal Muscular Atrophy (SMA) Type 4 represents a significant neurological condition that affects adults, typically manifesting after age 30. Our advanced SMN1 Gene Spinal Muscular Atrophy Type 4 NGS Genetic DNA Test provides a comprehensive genetic analysis to identify mutations in the SMN1 (Survival Motor Neuron 1) gene, which is responsible for this progressive neuromuscular disorder. This cutting-edge test represents a breakthrough in neurological genetic diagnostics, offering individuals and families crucial information for proactive health management.

What Does This Test Measure and Detect?

Our specialized NGS-based genetic test specifically targets and analyzes the SMN1 gene located on chromosome 5q13. The test detects:

  • Homozygous deletions of exon 7 in the SMN1 gene
  • Point mutations and small sequence variations
  • Gene conversion events between SMN1 and SMN2 genes
  • Copy number variations affecting SMN1 functionality
  • Specific genetic markers associated with SMA Type 4 onset and progression

The test utilizes state-of-the-art Next-Generation Sequencing technology, providing unparalleled accuracy in detecting even the most subtle genetic variations that contribute to SMA Type 4 development.

Who Should Consider This Genetic Test?

This comprehensive genetic screening is recommended for individuals experiencing:

  • Progressive muscle weakness beginning in adulthood
  • Family history of Spinal Muscular Atrophy
  • Unexplained muscle atrophy or fasciculations
  • Difficulty with walking, climbing stairs, or rising from chairs
  • Planning pregnancy with known SMA family history
  • Neurological symptoms suggestive of motor neuron disease
  • Individuals with siblings or parents diagnosed with SMA

Key Benefits of SMN1 Genetic Testing

Undergoing the SMN1 Gene Spinal Muscular Atrophy Type 4 test provides numerous advantages:

  • Early Detection and Intervention: Identify genetic predisposition before significant symptoms develop
  • Accurate Diagnosis: Differentiate SMA Type 4 from other neuromuscular conditions
  • Family Planning Guidance: Make informed reproductive decisions with genetic counseling
  • Treatment Planning: Enable timely access to emerging SMA therapies and interventions
  • Proactive Health Management: Implement preventive measures and monitoring strategies
  • Peace of Mind: Reduce uncertainty about genetic risk factors

Understanding Your Test Results

Our comprehensive genetic counseling support helps you interpret your results effectively:

  • Normal Result: No SMN1 gene mutations detected, indicating low risk for SMA Type 4
  • Carrier Status: Identification of one mutated SMN1 gene copy with implications for family planning
  • Affected Status: Detection of biallelic SMN1 mutations confirming SMA Type 4 diagnosis
  • Inconclusive Results: Rare cases requiring additional testing or family member analysis

All results are provided with detailed explanations and access to certified genetic counselors who specialize in neurological genetic disorders.

Test Pricing and Details

Test Component Details
Test Name SMN1 Gene Spinal Muscular Atrophy Type 4 NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Accessibility and Support

We maintain comprehensive testing facilities across the United States, with specialized centers in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures convenient access to advanced genetic testing regardless of your location.

Before testing, we recommend a genetic counseling session to discuss your clinical history and create a detailed family pedigree chart. This preparatory step ensures optimal test interpretation and personalized guidance.

Take Control of Your Neurological Health Today

Don’t let uncertainty about genetic risks impact your future. Our SMN1 Gene Spinal Muscular Atrophy Type 4 NGS Genetic DNA Test provides the clarity and confidence you need for informed health decisions. With our discounted price of $500 USD and comprehensive support services, there’s never been a better time to prioritize your genetic health.

Ready to schedule your test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Our team is available to answer your questions and guide you through the testing process with compassion and expertise.